Nasdaq Stockholm

Moberg Pharma AB (publ)

ISIN SE0020353928Filings at the FI

At a glance

Most recent filing on July 7, 2026 — a grant by Annika Christine Magnusson on Jul 7, 2026.

We hold 7 visible filings, going back to June 10, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 7 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Annika Christine Magnusson Other member of the administrative, management or supervisory body
110,361 SEKGrant
TradedJul 7, 2026FiledJul 7, 2026
Anna Helena Constance Ljung Chief executive officer
183,933 SEKGrant
TradedJul 7, 2026FiledJul 7, 2026
Mark Beveridge Chief financial officer
104,617 SEKGrant
TradedJul 7, 2026FiledJul 7, 2026
Isabelle Ducellier Board member
29,997 SEKOpen-market buy
TradedJun 12, 2025FiledJun 12, 2025
Isabelle Ducellier Board member
19,998 SEKOpen-market buy
TradedJun 3, 2025FiledJun 3, 2025